SEC Comment Letter 0000000000-23-011007 to HEALTHY CHOICE WELLNESS CORP. (HCWC)
HEALTHY CHOICE WELLNESS CORP.
Date: Oct. 5, 2023 · CIK: 0001948864 · Accession: 0000000000-23-011007
AI Filing Summary & Sentiment
File numbers found in text: 333-274435
Show Raw Text
United States securities and exchange commission logo
October 5, 2023
Jeffrey Holman
Chief Executive Officer
Healthy Choice Wellness Corp.
3800 North 28th Way
Hollywood, FL 33020
Re:Healthy Choice Wellness Corp.
Registration Statement on Form S-1
Filed September 8, 2023
File No. 333-274435
Dear Jeffrey Holman:
We have reviewed your registration statement and have the following comments.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments.
Form S-1 Filed September 8, 2023
Prospectus Cover Page, page ii
1.We note disclosure that you expect the offering price per share to be $10.00. Please revise
for consistency and accuracy. If you are not fixing the offering price, please revise your
offering statement to provide a price range per Rule 253(b). If you are fixing the offering
price, please revise your offering statement to clarify that $10.00 is not the expected per
share offering price but is the per share offering price.
Capitalization, page 31
2.Please revise your capitalization table to include a column for pro forma prior to the IPO.
Please only give effect to the issuance and distribution of common stock in the spin-off
transaction and issuance of Series A Convertible Preferred Stock in the pro forma column.
FirstName LastNameJeffrey Holman
Comapany NameHealthy Choice Wellness Corp.
October 5, 2023 Page 2
FirstName LastName
Jeffrey Holman
Healthy Choice Wellness Corp.
October 5, 2023
Page 2
Dilution, page 32
3.Please tell us your calculation of the $9 million historical net tangible book value as of
June 30, 2023. In addition, tell us why the shares outstanding after the offering of
9,400,000 differ from the 8,475,000 presented in the capitalization table.
Unaudited Pro Forma Condensed Combined Carve-Out Financial Information, page 36
4.Please present the pro forma condensed combined carve-out balance sheet as of the end of
the most recent period and pro forma condensed combined carve-out statements of
operations for the most recent interim period presented in your filing. Refer to Rules 11-
02(c)(1) and (c)(2)(i) of Regulation S-X.
5.We reissue comment 4. Please revise your pro forma financial information introductory
paragraph to describe all transactions reflected in the pro forma financial statements,
including the issuance and distribution of common shares in the spin-off transaction, the
issuance of 13,250 shares of Series A Convertible Preferred Stock, and $1 million
investment from HCMC. Refer to Rule 11-02(a)(2) of Regulation S-X.
6.We note your response to comment 6. Please revise your pro forma condensed combined
carve-out balance sheet to reflect your new capital structure post spin-off transaction.
Please also present earnings per share information in your pro forma condensed combined
carve-out statements of operations.
Non-GAAP Financial Measures, page 44
7.Please revise your reconciliation of adjusted EBITDA to begin with net loss, the most
directly comparable GAAP financial measure. Refer to Question 103.02 of the Non-
GAAP Financial Measures Compliance and Disclosure Interpretations.
General
8.We note your response to comment 7. Please provide us with your significance
calculations for Mothers Earth’s Storehouse and Green’s Natural Foods, Inc. acquisitions
in accordance with Rule 3-05(b) of Regulation S-X.
9.We are still considering your response to comments 1 and 2 in your April 7, 2023
response letter, and we may have additional comments. As a related matter, please tell us
whether you have previously discussed with NYSE whether the spin off will comply with
the listing standards, and, if so, provide the name of the representative with whom
discussions were had.
10.We note that you have revised your filing and it appears that you are now conducting two
concurrent offerings. Before you file your next amendment, please address the following
with respect to these transactions:
•Disclose the relationship between the spin-off and your primary offering, including
the timing and reason of each transaction.
FirstName LastNameJeffrey Holman
Comapany NameHealthy Choice Wellness Corp.
October 5, 2023 Page 3
FirstName LastName
Jeffrey Holman
Healthy Choice Wellness Corp.
October 5, 2023
Page 3
•To the extent you intend for the offerings to close concurrently, please provide us
with your legal analysis as to your ability to register the primary offering prior to
completion of the spin-off.
•Disclose the reason and legal analysis as to your ability to register both transactions
in this registration statement.
11.We note your response to comment 1 that pursuant to the Securities Purchase Agreement
you will issue Series E Preferred Stock and Series A Preferred Stock. It also appears that
upon consummation of the spin-off you will have outstanding shares of Class A common
stock and Class B common stock. Please revise your risk factors, cover page and the
section entitled Description of HCWC's Capital Stock, to discuss the nature of any
disparate voting rights, including the number of votes per share in the prospectus
summary and risk factor sections. Please also discuss the risks posed by such capital
structure, including but not limited to, risks relating to the potential effects on the price of
your common stock, if any.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
Please contact Suying Li at 202-551-3335 or Joel Parker at 202-551-3651 if you have
questions regarding comments on the financial statements and related matters. Please contact
Scott Anderegg at 202-551-3342 or Jennifer López Molina at 202-551-3792 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services